News

Sound Pharmaceuticals, Inc. (SPI) is pleased to announce a Cooperative Grant award from the National Center for Advancing Translational Sciences (NCATS) at the NIH for $3.1M to support…
Read More...

AB Science SA together with the University of Chicago, announces the signing of an exclusive licensing agreement for conducting research on the prevention and treatment of humans…
Read More...

Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel drug target discovery and development of novel therapeutics, announced the execution of a global…
Read More...

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class…
Read More...

Cidara Therapeutics, Inc. a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections,…
Read More...

Sorrento Therapeutics, Inc. announced the signing of a merger agreement pursuant to which Sorrento will acquire ACEA Therapeutics, Inc. (“ACEA”). The acquisition will include late…
Read More...

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the initiation of crossover arms in two ongoing clinical trials of…
Read More...

Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced that based on Proof of Concept (POC) animal study…
Read More...

Innovation Pharmaceuticals announced that an independent Data Monitoring Committee (DMC) completed its scheduled review of interim safety data in the Company’s randomized, double-blind,…
Read More...

AbbVie a global research and development-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental…
Read More...

Servier, a global pharmaceutical company, announced that it has successfully completed its acquisition of Agios Pharmaceuticals' commercial, clinical, and research-stage oncology…
Read More...

Takeda Pharmaceutical Company Limited announced that it has completed the asset transfer associated with a portfolio of select non-core products in Japan to Teijin Pharma Limited…
Read More...

Piramal Pharma Limited's (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced that PPL has entered into an agreement to acquire a…
Read More...

Bioasis Technologies Inc. a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the…
Read More...

Pfizer Inc. and BioNTech SE announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19…
Read More...

An investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate’s…
Read More...

Iconovo AB (publ), a company developing complete inhalation products for a global market, announced that it has signed an agreement with the immunotherapy company Immune System…
Read More...

BridGene Biosciences, Inc., a biotechnology company using cutting-edge technology to discover and develop small molecules for hard-to-drug therapeutic targets, announced today a…
Read More...

Applied BioMath the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, announced a…
Read More...

Roche announced that the European Commission (EC) has approved Evrysdi (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients two months of age and older, with a…
Read More...